Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma

Proteomics

Volumn 8, Issue 15, 2008, Pages 3194-3203

  Okamura, Noboru ^a   Masuda, Taro ^b   Gotoh, Akinobu ^c   Shirakawa, Toshiro ^a   Terao, Shuji ^c   Kaneko, Naoki ^b,d   Suganuma, Kazuki ^b   Watanabe, Makoto ^b,d   Matsubara, Toshiya ^b,d   Seto, Ryota ^e   Matsumoto, Jun ^e   Kawakami, Megumi ^e   Yamamori, Motohiro ^e   Nakamura, Tsutomu ^a,e   Yagami, Tatsurou ^f   Sakaeda, Toshiyuki ^e,g   Fujisawa, Masato ^a   Nishimura, Osamu ^b,d   Okumura, Katsuhiko ^a,e,f  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIMADZU CORPORATION   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e KOBE UNIVERSITY   (Japan)

^f HIMEJI DOKKYO UNIVERSITY   (Japan)

^g KYOTO UNIVERSITY   (Japan)

Author keywords

Biomarker; NBS method; Renal cell carcinoma

Indexed keywords

2 NITROBENZENESULFENYL; BIOLOGICAL MARKER; REAGENT; TRYPSIN; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER DIAGNOSIS; CANCER RESISTANCE; EXTRACTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN METABOLISM; PROTEOMICS; QUANTITATIVE ANALYSIS; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLING; TRYPSIN DIGESTION; UNINDEXED SEQUENCE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROTEOME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 49749108571     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700619     Document Type: Article

References (33)

1. Amato, R. J., Renal cell carcinoma: Review of novel single-agent therapeutics and combination regimens. Ann. Oncol. 2005, 16, 7-15.
2. Garcia, J. A., Rini, B. I., Recent progress in the management of advanced renal cell carcinoma. CA Cancer J. Clin. 2007, 57, 112-125.
3. Rabilloud, T., Two-dimensional gel electrophoresis in proteomics: Old, old fashioned, but it still climbs up the mountains. Proteomics 2002, 2, 3-10.
4. Kyte, J., Doolittle, R. F., A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 1982, 157, 105-132.
5. Gygi, S. P., Corthals, G. L., Zhang, Y., Rochon, Y., Aebersold, R., Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc. Natl. Acad. Sci. USA 2000, 97, 9390-9395.
6. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F. et al., Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17, 994-999.
7. Kuyama, H., Watanabe, M., Toda, C., Ando, E. et al., An approach to quantitative proteome analysis by labeling tryptophan residues. Rapid Commun. Mass Spectrom. 2003, 17, 1642-1650.
8. Matsuo, E., Toda, C., Watanabe, M., Iida, T. et al., Improved 2-nitrobenzenesulfenyl method: Optimization of the protocol and improved enrichment for labeled peptides. Rapid Commun. Mass Spectrom. 2006, 20, 31-38.
9. Matsuo, E., Toda, C., Watanabe, M., Ojima, N. et al., Selective detection of 2-nitrobenzenesulfenyl-labeled peptides by matrix-assisted laser desorption/ionization-time of flight mass spectrometry using a novel matrix. Proteomics 2006, 6, 2042-2049.
10. Cagney, G., Amiri, S., Premawaradena, T., Lindo, M. et al., In silico proteome analysis to facilitate proteomics experiments using mass spectrometry. Proteome Sci. 2003, 13, 5.
11. Iida, T., Kuyama, H., Watanabe, M., Toda, C. et al., Rapid and efficient MALDI-TOF MS peak detection of 2-nitrobenzene-sulfenyl labeled peptides using the combination of HPLC and an automatic spotting apparatus. J. Biomol. Technol. 2006, 17, 333-341.
12. Watanabe M., Takemasa I., Kawaguchi N., Miyake M. et al. An application of the 2-nitrobenzenesulfenyl (NBS) method to proteomic profiling of human colorectal carcinoma: A novel approach for biomarker discovery. Proteomics Clin. Appl. 2008, 2, 925-935.
13. Nakamura, T., Sakaeda, T., Horinouchi, M., Tamura, T. et al., Effect of the m utation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin. Pharmacol. Ther. 2002, 71, 297-303.
14. Kawakami, M., Nakamura, T., Okamura, N., Komoto, C. et al., Knock-down of sorcin induces up-regulation of MDR1 in HeU cells. Biol. Pharm. Bull. 2007, 30, 1065-1073.
15. Ferguson, R. E., Carroll, H. P., Harris, A., Maher, E. R. et al., Housekeeping proteins: A preliminary study illustrating some limitations as useful references in protein expression studies. Proteomics 2005, 5, 566-571.
16. Unwin, R. D., Craven, R. A., Harnden, P., Hanrahan, S. et al., Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics 2003, 3, 1620-1632.
17. Takashi, M., Haimoto, H., Tanaka, J., Murase, T. et al., Evaluation of gamma-enolase as a tumor marker for renal cell carcinoma. J. Urol. 1989, 141, 830-834.
18. Perroud, B., Lee, J., Valkova, N., Dhirapong, A. et al., Pathway analysis of kidney cancer using proteomics and metabolic profiling. Mol. Cancer 2006, 5, 64.
19. Seliger, B., Lichtenfels, R., Atkins, D., Bukur, J. et al., Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma. Proteomics 2005, 5, 2631-2640.
20. Hwa, J. S., Kim, H. J., Goo, B. M., Park, H. J. et al., The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma. Proteomics 2006, 6, 1077-1084.
21. Seliger, B., Fedorushchenko, A., Brenner, W., Ackermann, A. et al., Ubiquitin COOH-terminal hydrolase 1: A biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration. Clin. Cancer Res. 2007, 13, 27-37.
22. Ingrassia, L., Camby, I., Lefranc, F., Mathieu, V. et al., Anti-galectin compounds as potential anti-cancer drugs. Curr. Med. Chem. 2006, 13, 3513-3527.
23. Camby, I., Le Mercier, M., Lefranc, F., Kiss, R., Galectin-1: A small protein with major functions. Glycobiology 2006, 16, 137R-157R.
24. Fischer, C., Sanchez-Ruderisch, H., Welzel, M., Wiedenmann, B. et al., Galectin-1 interacts with the α5β1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J. Biol. Chem. 2005, 280, 37266-37277.
25. Andre, S., Kaltner, H., Lensch, M., Russwurm, R. et al., Determination of structural and functional overlap/divergence of five proto-type galectins by analysis of the growth-regulatory interaction with ganglioside GM1 in silico and in vitro on human neuroblastoma cells. Int. J. Cancer 2005, 114, 46-57.
26. Elad-Sfadia, G., Haklai, R., Ballan, E., Gabius, H. J., Kloog, Y., Galectin-1 augments Ras activation and diverts Ras signals to Raf-1 at the expense of phosphoinositide 3-kinase. J. Biol. Chem. 2002, 277, 37169-37175.
27. Grutzmann, R., Pilarsky, C., Ammerpohl, O., Luttges, J. et al., Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 2004, 6, 611-622.
28. Shen, J., Person, M. D., Zhu, J., Abbruzzese, J. L., Li, D., Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res. 2004, 64, 9018-9026.
29. Gabius, H. J., Andre, S., Gunsenhauser, I., Kaltner, H. et al., Association of galectin-1- but not galectin-3 dependent parameters with proliferation activity in human neuroblastomas and small cell lung carcinomas. Anticancer Res. 2002, 22, 405-410.
30. Szoke, T., Kayser, K., Baumhakel, J. D., Trojan, I. et al., Prognostic significance of endogenous adhesion/growth-regulatory lectins in lung cancer. Oncology 2005, 69, 167-174.
31. Teufel, M., Saudek, V., Ledig, J.-P., Bernhardt, A. et al.. Sequence identification and characterization of human carnosinase and a closely related nonspecific dipeptidase. J. Biol. Chem. 2003, 278, 6521-6531.
32. Bart, J., Daniela, H., Paul, B., Verena, P. et al., Carnosine as a protective factor in diabetic nephropathy association with a leucine repeat of the carcinase gene CNDP1. Diabetes 2005, 54, 2320-2327.
33. Pingping, Z., David, W. C., Yi, Y. Z., Jin, J. L. et al., Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma. Clin. Cancer Res. 2006, 12, 6617-6625.